Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

Acute Management of Optic Neuritis: An Evolving Paradigm.

Horton L, Bennett JL.

J Neuroophthalmol. 2018 Sep;38(3):358-367. doi: 10.1097/WNO.0000000000000700.

PMID:
30106803
2.

Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport.

Mader S, Brimberg L, Soltys JN, Bennett JL, Diamond B.

Front Immunol. 2018 Jul 13;9:1599. doi: 10.3389/fimmu.2018.01599. eCollection 2018.

3.

Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Jul 26. pii: S0002-9394(18)30401-X. doi: 10.1016/j.ajo.2018.07.020. [Epub ahead of print]

PMID:
30055153
4.

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.

Peschl P, Schanda K, Zeka B, Given K, Böhm D, Ruprecht K, Saiz A, Lutterotti A, Rostásy K, Höftberger R, Berger T, Macklin W, Lassmann H, Bradl M, Bennett JL, Reindl M.

J Neuroinflammation. 2017 Oct 25;14(1):208. doi: 10.1186/s12974-017-0984-5.

5.

Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.

Shimizu F, Schaller KL, Owens GP, Cotleur AC, Kellner D, Takeshita Y, Obermeier B, Kryzer TJ, Sano Y, Kanda T, Lennon VA, Ransohoff RM, Bennett JL.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaai9111. doi: 10.1126/scitranslmed.aai9111.

6.

CNS Aquaporin-4-specific B cells connect with multiple B-cell compartments in neuromyelitis optica spectrum disorder.

Kowarik MC, Astling D, Gasperi C, Wemlinger S, Schumann H, Dzieciatkowska M, Ritchie AM, Hemmer B, Owens GP, Bennett JL.

Ann Clin Transl Neurol. 2017 May 9;4(6):369-380. doi: 10.1002/acn3.418. eCollection 2017 Jun.

7.

Comparative molecular dynamics study of neuromyelitis optica-immunoglobulin G binding to aquaporin-4 extracellular domains.

Alberga D, Trisciuzzi D, Lattanzi G, Bennett JL, Verkman AS, Mangiatordi GF, Nicolotti O.

Biochim Biophys Acta Biomembr. 2017 Aug;1859(8):1326-1334. doi: 10.1016/j.bbamem.2017.05.001. Epub 2017 May 3.

8.

Determining the Spatial Relationship of Membrane-Bound Aquaporin-4 Autoantibodies by STED Nanoscopy.

Soltys JN, Meyer SA, Schumann H, Gibson EA, Restrepo D, Bennett JL.

Biophys J. 2017 Apr 25;112(8):1692-1702. doi: 10.1016/j.bpj.2017.03.012.

9.

Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.

Bennett JL, Owens GP.

J Neuroophthalmol. 2017 Sep;37(3):291-299. doi: 10.1097/WNO.0000000000000508. Review. No abstract available.

10.

Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.

Liu Y, Given KS, Harlow DE, Matschulat AM, Macklin WB, Bennett JL, Owens GP.

Acta Neuropathol Commun. 2017 Mar 24;5(1):25. doi: 10.1186/s40478-017-0428-6.

11.

Outcomes of a Therapeutic Fly-Fishing Program for Veterans with Combat-Related Disabilities: A Community-Based Rehabilitation Initiative.

Bennett JL, Piatt JA, Van Puymbroeck M.

Community Ment Health J. 2017 Oct;53(7):756-765. doi: 10.1007/s10597-017-0124-9. Epub 2017 Mar 16.

PMID:
28303444
12.

Deletional tolerance prevents AQP4-directed autoimmunity in mice.

Vogel AL, Knier B, Lammens K, Kalluri SR, Kuhlmann T, Bennett JL, Korn T.

Eur J Immunol. 2017 Mar;47(3):458-469. doi: 10.1002/eji.201646855. Epub 2017 Jan 25.

13.

Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4.

Sagan SA, Winger RC, Cruz-Herranz A, Nelson PA, Hagberg S, Miller CN, Spencer CM, Ho PP, Bennett JL, Levy M, Levin MH, Verkman AS, Steinman L, Green AJ, Anderson MS, Sobel RA, Zamvil SS.

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14781-14786. doi: 10.1073/pnas.1617859114. Epub 2016 Dec 8.

14.

Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting.

Kumpe DA, Seinfeld J, Huang X, Mei Q, Case DE, Roark CD, Subramanian PS, Lind KE, Pelak VS, Bennett JL.

J Neurointerv Surg. 2017 Sep;9(9):867-874. doi: 10.1136/neurintsurg-2016-012810. Epub 2016 Nov 8.

PMID:
27935482
15.

Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica.

Liu Y, Harlow DE, Given KS, Owens GP, Macklin WB, Bennett JL.

J Neuroinflammation. 2016 Dec 1;13(1):301.

16.

Efficacy of Polyvalent Human Immunoglobulins in an Animal Model of Neuromyelitis Optica Evoked by Intrathecal Anti-Aquaporin 4 Antibodies.

Grünewald B, Bennett JL, Toyka KV, Sommer C, Geis C.

Int J Mol Sci. 2016 Aug 26;17(9). pii: E1407. doi: 10.3390/ijms17091407.

17.

Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.

Bennett JL.

J Neuroophthalmol. 2016 Sep;36(3):238-45. doi: 10.1097/WNO.0000000000000396. Review.

18.

A comprehensive transcriptional map of primate brain development.

Bakken TE, Miller JA, Ding SL, Sunkin SM, Smith KA, Ng L, Szafer A, Dalley RA, Royall JJ, Lemon T, Shapouri S, Aiona K, Arnold J, Bennett JL, Bertagnolli D, Bickley K, Boe A, Brouner K, Butler S, Byrnes E, Caldejon S, Carey A, Cate S, Chapin M, Chen J, Dee N, Desta T, Dolbeare TA, Dotson N, Ebbert A, Fulfs E, Gee G, Gilbert TL, Goldy J, Gourley L, Gregor B, Gu G, Hall J, Haradon Z, Haynor DR, Hejazinia N, Hoerder-Suabedissen A, Howard R, Jochim J, Kinnunen M, Kriedberg A, Kuan CL, Lau C, Lee CK, Lee F, Luong L, Mastan N, May R, Melchor J, Mosqueda N, Mott E, Ngo K, Nyhus J, Oldre A, Olson E, Parente J, Parker PD, Parry S, Pendergraft J, Potekhina L, Reding M, Riley ZL, Roberts T, Rogers B, Roll K, Rosen D, Sandman D, Sarreal M, Shapovalova N, Shi S, Sjoquist N, Sodt AJ, Townsend R, Velasquez L, Wagley U, Wakeman WB, White C, Bennett C, Wu J, Young R, Youngstrom BL, Wohnoutka P, Gibbs RA, Rogers J, Hohmann JG, Hawrylycz MJ, Hevner RF, Molnár Z, Phillips JW, Dang C, Jones AR, Amaral DG, Bernard A, Lein ES.

Nature. 2016 Jul 21;535(7612):367-75. doi: 10.1038/nature18637. Epub 2016 Jul 13.

19.

Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases.

Weil MT, Möbius W, Winkler A, Ruhwedel T, Wrzos C, Romanelli E, Bennett JL, Enz L, Goebels N, Nave KA, Kerschensteiner M, Schaeren-Wiemers N, Stadelmann C, Simons M.

Cell Rep. 2016 Jul 12;16(2):314-322. doi: 10.1016/j.celrep.2016.06.008. Epub 2016 Jun 23.

20.

Persistent disparities in obesity risk among public schoolchildren from childhood through adolescence.

Chen D, Thomsen MR, Nayga RM Jr, Bennett JL.

Prev Med. 2016 Aug;89:207-210. doi: 10.1016/j.ypmed.2016.06.010. Epub 2016 Jun 14.

PMID:
27311335
21.

In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.

Herwerth M, Kalluri SR, Srivastava R, Kleele T, Kenet S, Illes Z, Merkler D, Bennett JL, Misgeld T, Hemmer B.

Ann Neurol. 2016 Mar 6. doi: 10.1002/ana.24630. [Epub ahead of print]

22.

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.

Yan Y, Li Y, Fu Y, Yang L, Su L, Shi K, Li M, Liu Q, Borazanci A, Liu Y, He Y, Bennett JL, Vollmer TL, Shi FD.

Sci China Life Sci. 2016 Dec;59(12):1270-1281. Epub 2016 Feb 26.

23.

Sphenoid Wing Meningioma With Extraocular Muscle Involvement Mimicking Idiopathic Orbital Inflammation.

Rodríguez-Colón G, Bratton EM, Serracino H, Bennett JL, Hink EM.

Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3S Suppl 1):S97-S99. doi: 10.1097/IOP.0000000000000632.

PMID:
26882057
24.

Making good policy decisions: a discipline we cannot afford to ignore.

Bennett JL.

Transfusion. 2015 Dec;55(12):2775-7. doi: 10.1111/trf.13382. No abstract available.

PMID:
26771958
25.

Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.

Cree BA, Bennett JL, Sheehan M, Cohen J, Hartung HP, Aktas O, Kim HJ, Paul F, Pittock S, Weinshenker B, Wingerchuk D, Fujihara K, Cutter G, Patra K, Flor A, Barron G, Madani S, Ratchford JN, Katz E.

Mult Scler. 2016 Jun;22(7):862-72. doi: 10.1177/1352458515620934. Epub 2015 Dec 14.

26.

The Ins and Outs of B Cells in Multiple Sclerosis.

Blauth K, Owens GP, Bennett JL.

Front Immunol. 2015 Nov 5;6:565. doi: 10.3389/fimmu.2015.00565. eCollection 2015. Review.

27.

Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.

Blauth K, Soltys J, Matschulat A, Reiter CR, Ritchie A, Baird NL, Bennett JL, Owens GP.

Acta Neuropathol. 2015 Dec;130(6):765-81. doi: 10.1007/s00401-015-1500-6. Epub 2015 Oct 28.

28.

Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis.

Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, Poppiti RJ, Bockelman B, Keyvani K, Pollak L, Mendlovic S, Fowkes M, Eberhart CG, Buttmann M, Toyka KV, Meyer-ter-Vehn T, Petursdottir V, Gilden D.

JAMA Neurol. 2015 Nov;72(11):1281-7. doi: 10.1001/jamaneurol.2015.2101.

29.

Update on biomarkers in neuromyelitis optica.

Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, Han MH, Aktas O, Apiwattanakul M, Banwell B, Bichuetti D, Broadley S, Cabre P, Chitnis T, De Seze J, Fujihara K, Greenberg B, Hellwig K, Iorio R, Jarius S, Klawiter E, Kleiter I, Lana-Peixoto M, Nakashima, O'Connor K, Palace J, Paul F, Prayoonwiwat N, Ruprecht K, Stuve O, Tedder T, Tenembaum S, Garrahan JP, Aires B, van Herle K, van Pelt D, Villoslada P, Waubant E, Weinshenker B, Wingerchuk D, Würfel J, Zamvil S.

Neurol Neuroimmunol Neuroinflamm. 2015 Jul 23;2(4):e134. doi: 10.1212/NXI.0000000000000134. eCollection 2015 Aug. Review.

30.

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis.

Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.

31.

Varicella Zoster Virus in Ischemic Optic Neuropathy.

Golas L, Bennett JL, White TM, Skarf B, Lesser R, Nagel MA, Gilden D.

Ophthalmology. 2015 Oct;122(10):2142-5. doi: 10.1016/j.ophtha.2015.04.026. Epub 2015 Jun 6. No abstract available.

32.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT; Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K.

JAMA Neurol. 2015 Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248. Review.

33.

B lymphocytes in neuromyelitis optica.

Bennett JL, O'Connor KC, Bar-Or A, Zamvil SS, Hemmer B, Tedder TF, von Büdingen HC, Stuve O, Yeaman MR, Smith TJ, Stadelmann C.

Neurol Neuroimmunol Neuroinflamm. 2015 May 7;2(3):e104. doi: 10.1212/NXI.0000000000000104. eCollection 2015 Jun. Review.

34.

Spatiotemporal dynamics of the postnatal developing primate brain transcriptome.

Bakken TE, Miller JA, Luo R, Bernard A, Bennett JL, Lee CK, Bertagnolli D, Parikshak NN, Smith KA, Sunkin SM, Amaral DG, Geschwind DH, Lein ES.

Hum Mol Genet. 2015 Aug 1;24(15):4327-39. doi: 10.1093/hmg/ddv166. Epub 2015 May 7.

35.

Challenges and opportunities in designing clinical trials for neuromyelitis optica.

Weinshenker BG, Barron G, Behne JM, Bennett JL, Chin PS, Cree BA, de Seze J, Flor A, Fujihara K, Greenberg B, Higashi S, Holt W, Khan O, Knappertz V, Levy M, Melia AT, Palace J, Smith TJ, Sormani MP, Van Herle K, VanMeter S, Villoslada P, Walton MK, Wasiewski W, Wingerchuk DM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium.

Neurology. 2015 Apr 28;84(17):1805-15. doi: 10.1212/WNL.0000000000001520. Epub 2015 Apr 3. Review.

36.

Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.

Owens GP, Ritchie A, Rossi A, Schaller K, Wemlinger S, Schumann H, Shearer A, Verkman AS, Bennett JL.

J Biol Chem. 2015 May 8;290(19):12123-34. doi: 10.1074/jbc.M115.647149. Epub 2015 Mar 19.

37.

ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.

Sergott RC, Bennett JL, Rieckmann P, Montalban X, Mikol D, Freudensprung U, Plitz T, van Beek J; ATON Trial Group.

J Neurol Sci. 2015 Apr 15;351(1-2):174-178. doi: 10.1016/j.jns.2015.02.019. Epub 2015 Feb 17.

PMID:
25758472
38.

Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.

Gilden D, White T, Khmeleva N, Heintzman A, Choe A, Boyer PJ, Grose C, Carpenter JE, Rempel A, Bos N, Kandasamy B, Lear-Kaul K, Holmes DB, Bennett JL, Cohrs RJ, Mahalingam R, Mandava N, Eberhart CG, Bockelman B, Poppiti RJ, Tamhankar MA, Fogt F, Amato M, Wood E, Durairaj V, Rasmussen S, Petursdottir V, Pollak L, Mendlovic S, Chatelain D, Keyvani K, Brueck W, Nagel MA.

Neurology. 2015 May 12;84(19):1948-55. doi: 10.1212/WNL.0000000000001409. Epub 2015 Feb 18.

39.

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.

Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, Tenembaum S, Banwell B, Greenberg B, Levy M, Fujihara K, Chan KH, Kim HJ, Asgari N, Sato DK, Saiz A, Wuerfel J, Zimmermann H, Green A, Villoslada P, Paul F; GJCF-ICC&BR.

Mult Scler. 2015 May;21(6):678-88. doi: 10.1177/1352458514567216. Epub 2015 Feb 6. Review.

40.

Optimizing perioperative Crohn's disease management: role of coordinated medical and surgical care.

Bennett JL, Ha CY, Efron JE, Gearhart SL, Lazarev MG, Wick EC.

World J Gastroenterol. 2015 Jan 28;21(4):1182-8. doi: 10.3748/wjg.v21.i4.1182.

41.

The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations.

Kowarik MC, Dzieciatkowska M, Wemlinger S, Ritchie AM, Hemmer B, Owens GP, Bennett JL.

J Neuroinflammation. 2015 Jan 28;12:19. doi: 10.1186/s12974-015-0240-9.

42.

The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model.

Geis C, Ritter C, Ruschil C, Weishaupt A, Grünewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV.

Exp Neurol. 2015 Mar;265:8-21. doi: 10.1016/j.expneurol.2014.12.015. Epub 2014 Dec 24.

43.

Implementation of surgical quality improvement: auditing tool for surgical site infection prevention practices.

Hechenbleikner EM, Hobson DB, Bennett JL, Wick EC.

Dis Colon Rectum. 2015 Jan;58(1):83-90. doi: 10.1097/DCR.0000000000000259.

PMID:
25489698
44.

Re-evaluating the treatment of acute optic neuritis.

Bennett JL, Nickerson M, Costello F, Sergott RC, Calkwood JC, Galetta SL, Balcer LJ, Markowitz CE, Vartanian T, Morrow M, Moster ML, Taylor AW, Pace TW, Frohman T, Frohman EM.

J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):799-808. doi: 10.1136/jnnp-2014-308185. Epub 2014 Oct 29. Review.

45.

Evaluation of aquaporin-4 antibody assays.

Waters PJ, Pittock SJ, Bennett JL, Jarius S, Weinshenker BG, Wingerchuk DM.

Clin Exp Neuroimmunol. 2014 Oct;5(3):290-303. Epub 2014 Apr 22.

46.

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Papadopoulos MC, Bennett JL, Verkman AS.

Nat Rev Neurol. 2014 Sep;10(9):493-506. doi: 10.1038/nrneurol.2014.141. Epub 2014 Aug 12. Review.

47.

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.

Saadoun S, Waters P, Owens GP, Bennett JL, Vincent A, Papadopoulos MC.

Acta Neuropathol Commun. 2014 Mar 31;2:35. doi: 10.1186/2051-5960-2-35.

48.

The treatment of neuromyelitis optica.

Kowarik MC, Soltys J, Bennett JL.

J Neuroophthalmol. 2014 Mar;34(1):70-82. doi: 10.1097/WNO.0000000000000102. Review.

49.

Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.

Asavapanumas N, Ratelade J, Papadopoulos MC, Bennett JL, Levin MH, Verkman AS.

J Neuroinflammation. 2014 Jan 27;11:16. doi: 10.1186/1742-2094-11-16.

50.

Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.

Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, Brück W, Nessler S, Bennett JL, Stadelmann C.

Acta Neuropathol. 2014 Apr;127(4):523-38. doi: 10.1007/s00401-013-1220-8. Epub 2013 Nov 30.

Supplemental Content

Loading ...
Support Center